在质母细胞瘤中通过瘤病毒介导的免疫调节:来自临床试验的见解和挑战
Raziye Piranlioglu1, E Antonio Chiocca2
1Harvey Cushing Neuro-oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Seminars in immunology
|June 24, 2025
概括
瘤病毒 (OVs) 通过激活免疫系统,在治疗质母细胞瘤 (GBM) 中表现有前途. 虽然通常是安全的,但由于临床试验中的采样限制,分析治疗效果仍然存在挑战.
科学领域:
- 神经瘤学神经瘤学
- 免疫治疗是一种免疫疗法.
- 病毒学 病毒学
背景情况:
- 主体免疫系统在癌症治疗中至关重要,这导致了免疫治疗的兴起.
- 质母细胞瘤 (GBM) 呈现出高度免疫抑制的瘤微环境,阻碍了T细胞对瘤的有效反应.
- 抗原特异性免疫疗法在克服GBM的免疫抑制性方面面临重大挑战.
研究的目的:
- 审查瘤细胞母细胞瘤 (GBM) 抗瘤病毒 (OV) 治疗的进展.
- 讨论OVs在调节GBM微环境以实现免疫活性状态方面的潜力.
- 确定GBM的OV临床试验当前的挑战和未来的方向.
主要方法:
- 对临床试验数据和关于质母细胞瘤瘤病毒的科学文献的综述.
- 关于OV引起的GBM微环境变化的证据分析.
- 在OV试验中报告的安全性,疗效和免疫效应的评估.
主要成果:
- 瘤病毒 (OV) 显示出将免疫抑制性GBM微环境转化为免疫活性微环境的潜力.
- 临床试验表明,性病毒疗法通常耐受良好,可以激活抗瘤免疫反应.
- 机会之窗试验为病毒复制,免疫反应和分娩提供了洞察力,但面临样本限制.
结论:
- 瘤病毒代表了质母细胞瘤的一个有前途的免疫治疗策略.
- 用OVs调节GBM微环境可以增强抗瘤免疫力.
- 需要进一步的研究,以克服分析治疗诱导的变化和优化OV治疗GBM的挑战.
更多相关视频
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.0K
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.5K
相关概念视频
01:27Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:30Cancer Vaccines
520
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
520